Stay updated on Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:17:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision note updated from v3.4.1 to v3.4.2; no other page content changes to the study details, eligibility, or locations are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T09:51:28.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and the prior Revision: v3.4.0 has been removed.
    Difference
    0.0%
    Check dated 2026-02-07T08:34:47.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Show glossary added and page metadata updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T07:51:03.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The revision tag updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-17T06:22:04.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Locations section updated with new sites in California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Washington, Ontario, and Michigan, and removals from the list (revision 3.3.3 vs 3.3.2).
    Difference
    1%
    Check dated 2025-12-19T14:07:52.000Z thumbnail image

Stay in the know with updates to Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-KIR & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.